Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation-Reference-Cited by-同舟云学术

Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

Published:2001-09 Issue:3 Volume:38 Page:814-818
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Weis Michael,Pehlivanli Sinan,Meiser Bruno M,von Scheidt Wolfgang

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Effects of pravastatin on outcome after cardiac transplantation;Kobashigawa;N Engl J Med,1995

2. Simvastatin reduces graft vessel disease and mortality after heart transplantation;Wenke;Circulation,1997

3. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia;Egashira;Circulation,1994

4. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion;Anderson;N Engl J Med,1995

5. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries;Hamasaki;Arterioscler Thromb Vasc Res,2000

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences;Transplantation;2023-10-30

2. Role of ascorbic acid in cardiac allograft vasculopathy;Clinical Transplantation;2023-10-04

3. Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart;Comprehensive Physiology;2023-06-26

4. Atorvastatin suppresses lipopolysaccharide-induced inflammation in human coronary artery endothelial cells;Brazilian Journal of Pharmaceutical Sciences;2022

5. Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation;CJC Open;2021-12